|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Schrodi, S.; Braun, M.; Andrulat, A.; Harbeck, N.; Mahner, S.; Kiechle, M.; Klein, E.; Schnelzer, A.; Schindlbeck, C.; Bauerfeind, I.; Schubert-Fritschle, Gabriele; Nekljudova, V.; Mayr, D.; Weichert, W.; Denkert, C.; Loibl, S. und Engel, J.
(2021):
Outcome of breast cancer patients with low hormone receptor positivity. Analysis of a 15-year population-based cohort.
In: Annals of Oncology, Bd. 32, Nr. 11: S. 1410-1424
[PDF, 1MB]
Wuerstlein, R.; Sotlar, K.; Gluz, O.; Hofmann, D.; Otremba, B.; Schumann, R. von; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Morel, P.; Cowens, W.; Hornberger, J.; Kates, R. E.; Pelz, E. und Harbeck, N.
(2016):
Prosigna®(R) results impact on adjuvant decision making in early breast cancer (EBC): Final analysis of the prospective WSG study.
In: Cancer Research, Bd. 76
Wuerstlein, R.; Sotlar, K.; Gluz, O.; Hofmann, D.; Otremba, B.; Schumann, R. von; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Morel, P.; Cowens, W.; Hornberger, A.; Kates, R. E.; Pelz, E. und Harbeck, N.
(2016):
Prosigna® results impact on adjuvant decision making in early breast cancer (EBC): Final analysis of the prospective WSG study.
In: Oncology Research and Treatment, Bd. 39: S. 49
Wuerstlein, R.; Sotlar, K.; Gluz, O.; Otremba, B.; Schumann, R. von; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Ghali, N.; Orujov, E.; Kates, R. E.; Cowens, W.; Hornberger, J.; Pelz, E. und Harbeck, N.
(2016):
The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer.
In: Current Medical Research and Opinion, Bd. 32, Nr. 7: S. 1217-1224
Kolben, T.; Harbeck, N.; Wuerstlein, R.; Schubert-Fritschle, Gabriele; Bauerfeind, I.; Schrodi, Simone und Engel, Jutta
(2015):
Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
In: Breast, Bd. 24, Nr. 1: S. 24-31
Hermelink, K.; Henschel, Volkmar; Untch, M.; Bauerfeind, I.; Lux, M. P. und Munzel, K.
(2008):
Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
In: Cancer, Bd. 113, Nr. 9: S. 2431-2439
Janni, W.; Rack, B.; Gerber, B.; Bauerfeind, I.; Krause, A.; Dian, D.; Sommer, H. und Friese, K.
(2006):
Pregnancy-associated breast cancer - Special features in diagnosis and treatment.
In: Onkologie, Nr. 3: S. 107-112
[PDF, 58kB]
Strauss, Alexander; Hasbargen, U.; Paek, Bettina; Bauerfeind, I. und Hepp, Hermann
(2000):
Intra-uterine fetal demise caused by amniotic band syndrome after standard amniocentesis.
In: Fetal Diagnosis and Therapy, Nr. 1: S. 4-7
[PDF, 267kB]